KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other financing activities (2018 - 2025)

Historic Other financing activities for Guardant Health (GH) over the last 8 years, with Q2 2025 value amounting to $151000.0.

  • Guardant Health's Other financing activities rose 13447.49% to $151000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 270000.0%. This contributed to the annual value of -$153000.0 for FY2024, which is 10072.41% down from last year.
  • As of Q2 2025, Guardant Health's Other financing activities stood at $151000.0, which was up 13447.49% from $12.1 million recorded in Q1 2025.
  • In the past 5 years, Guardant Health's Other financing activities registered a high of $21.3 million during Q2 2023, and its lowest value of -$1.7 million during Q4 2021.
  • Moreover, its 5-year median value for Other financing activities was $20500.0 (2022), whereas its average is $2.2 million.
  • Per our database at Business Quant, Guardant Health's Other financing activities tumbled by 10205.74% in 2024 and then skyrocketed by 462295.72% in 2025.
  • Over the past 5 years, Guardant Health's Other financing activities (Quarter) stood at -$1.7 million in 2021, then surged by 98.95% to -$18000.0 in 2022, then skyrocketed by 3727.78% to $653000.0 in 2023, then plummeted by 90.96% to $59000.0 in 2024, then skyrocketed by 155.93% to $151000.0 in 2025.
  • Its Other financing activities was $151000.0 in Q2 2025, compared to $12.1 million in Q1 2025 and $59000.0 in Q4 2024.